Stock Market News2 weeks ChromaDex (CDXC) Q4 Earnings and Revenues Surpass Estimates Zacks
ChromaDex (CDXC) delivered earnings and revenue surprises of 50% and 7.47%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
X